SonoScape Medical Corp (300633) - Net Assets
Based on the latest financial reports, SonoScape Medical Corp (300633) has net assets worth CN¥3.26 Billion CNY (≈ $477.54 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.30 Billion ≈ $629.09 Million USD) and total liabilities (CN¥1.04 Billion ≈ $151.55 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of SonoScape Medical Corp to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.26 Billion |
| % of Total Assets | 75.91% |
| Annual Growth Rate | 18.69% |
| 5-Year Change | 38.52% |
| 10-Year Change | 353.05% |
| Growth Volatility | 20.8 |
SonoScape Medical Corp - Net Assets Trend (2012–2025)
This chart illustrates how SonoScape Medical Corp's net assets have evolved over time, based on quarterly financial data. See SonoScape Medical Corp (300633) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for SonoScape Medical Corp (2012–2025)
The table below shows the annual net assets of SonoScape Medical Corp from 2012 to 2025. For live valuation and market cap data, see 300633 market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥3.26 Billion ≈ $477.40 Million |
+4.96% |
| 2024-12-31 | CN¥3.11 Billion ≈ $454.83 Million |
-1.20% |
| 2023-12-31 | CN¥3.15 Billion ≈ $460.35 Million |
+14.82% |
| 2022-12-31 | CN¥2.74 Billion ≈ $400.92 Million |
+16.33% |
| 2021-12-31 | CN¥2.36 Billion ≈ $344.64 Million |
+75.11% |
| 2020-12-31 | CN¥1.34 Billion ≈ $196.81 Million |
-4.22% |
| 2019-12-31 | CN¥1.40 Billion ≈ $205.49 Million |
+7.11% |
| 2018-12-31 | CN¥1.31 Billion ≈ $191.84 Million |
+23.75% |
| 2017-12-31 | CN¥1.06 Billion ≈ $155.02 Million |
+47.11% |
| 2016-12-31 | CN¥720.11 Million ≈ $105.38 Million |
+27.18% |
| 2015-12-31 | CN¥566.21 Million ≈ $82.85 Million |
+27.29% |
| 2014-12-31 | CN¥444.81 Million ≈ $65.09 Million |
+21.84% |
| 2013-12-31 | CN¥365.08 Million ≈ $53.42 Million |
+3.77% |
| 2012-12-31 | CN¥351.82 Million ≈ $51.48 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SonoScape Medical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 549.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.57 Billion | 48.04% |
| Other Components | CN¥1.70 Billion | 51.96% |
| Total Equity | CN¥3.26 Billion | 100.00% |
SonoScape Medical Corp Competitors by Market Cap
The table below lists competitors of SonoScape Medical Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
JiShi Media Co Ltd
SHG:601929
|
$1.14 Billion |
|
Liberty Latin America Ltd Class C
NASDAQ:LILAK
|
$1.14 Billion |
|
COMPUGROUP MED.SP.ADR 1
F:COPA
|
$1.14 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
$1.14 Billion |
|
Lontium Semiconductor Corp. A
SHG:688486
|
$1.14 Billion |
|
Anhui Estone Materials Technology Co Ltd
SHG:688733
|
$1.14 Billion |
|
Parksystems Corp
KQ:140860
|
$1.14 Billion |
|
Red Star Macalline Group Corp Ltd Class A
SHG:601828
|
$1.14 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SonoScape Medical Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,108,222,479 to 3,262,490,485, a change of 154,268,006 (5.0%).
- Net income of 197,280,077 contributed positively to equity growth.
- Dividend payments of 47,233,382 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥197.28 Million | +6.05% |
| Dividends Paid | CN¥47.23 Million | -1.45% |
| Other Changes | CN¥4.22 Million | +0.13% |
| Total Change | CN¥- | 4.96% |
Book Value vs Market Value Analysis
This analysis compares SonoScape Medical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.38x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 19.16x to 2.38x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | CN¥0.94 | CN¥17.97 | x |
| 2013-12-31 | CN¥1.03 | CN¥17.97 | x |
| 2014-12-31 | CN¥1.25 | CN¥17.97 | x |
| 2015-12-31 | CN¥1.55 | CN¥17.97 | x |
| 2016-12-31 | CN¥1.99 | CN¥17.97 | x |
| 2017-12-31 | CN¥2.73 | CN¥17.97 | x |
| 2018-12-31 | CN¥3.27 | CN¥17.97 | x |
| 2019-12-31 | CN¥3.51 | CN¥17.97 | x |
| 2020-12-31 | CN¥3.36 | CN¥17.97 | x |
| 2021-12-31 | CN¥5.89 | CN¥17.97 | x |
| 2022-12-31 | CN¥6.40 | CN¥17.97 | x |
| 2023-12-31 | CN¥7.27 | CN¥17.97 | x |
| 2024-12-31 | CN¥7.23 | CN¥17.97 | x |
| 2025-12-31 | CN¥7.54 | CN¥17.97 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SonoScape Medical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.05%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.54%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.35x
- Recent ROE (6.05%) is below the historical average (15.34%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 38.91% | 26.83% | 0.78x | 1.86x | CN¥96.55 Million |
| 2013 | 19.35% | 11.93% | 0.95x | 1.71x | CN¥34.14 Million |
| 2014 | 29.62% | 20.60% | 0.75x | 1.93x | CN¥87.27 Million |
| 2015 | 18.70% | 15.44% | 0.73x | 1.65x | CN¥49.25 Million |
| 2016 | 18.11% | 18.13% | 0.71x | 1.41x | CN¥58.42 Million |
| 2017 | 17.94% | 19.21% | 0.74x | 1.26x | CN¥84.08 Million |
| 2018 | 19.27% | 20.59% | 0.67x | 1.40x | CN¥121.52 Million |
| 2019 | 7.23% | 8.10% | 0.52x | 1.72x | CN¥-38.89 Million |
| 2020 | -3.44% | -3.98% | 0.52x | 1.67x | CN¥-180.76 Million |
| 2021 | 10.50% | 17.12% | 0.48x | 1.28x | CN¥11.73 Million |
| 2022 | 13.50% | 20.98% | 0.50x | 1.29x | CN¥95.83 Million |
| 2023 | 14.45% | 21.43% | 0.56x | 1.20x | CN¥139.84 Million |
| 2024 | 4.58% | 7.07% | 0.47x | 1.39x | CN¥-168.42 Million |
| 2025 | 6.05% | 8.54% | 0.52x | 1.35x | CN¥-128.97 Million |
Industry Comparison
This section compares SonoScape Medical Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,164,732,019
- Average return on equity (ROE) among peers: 16.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SonoScape Medical Corp (300633) | CN¥3.26 Billion | 38.91% | 0.32x | $1.14 Billion |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $1.27 Billion | 23.03% | 0.13x | $346.22 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $1.52 Billion | 17.01% | 0.20x | $3.75 Billion |
| Double Medical Technology Inc (002901) | $1.24 Billion | 23.86% | 0.12x | $2.54 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $13.60 Million | 53.86% | 0.75x | $485.54 Million |
| Lepu Medical Tech Beijing (300003) | $10.54 Billion | 17.10% | 0.73x | $3.07 Billion |
| INKON Life Technology Co Ltd (300143) | $2.24 Billion | 5.72% | 0.18x | $720.52 Million |
| Edan Instruments Inc (300206) | $1.16 Billion | 1.16% | 0.17x | $1.01 Billion |
| Guangdong Biolight Meditech Co Ltd (300246) | $992.38 Million | 6.43% | 0.73x | $562.22 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $433.85 Million |
| Sinocare Inc (300298) | $1.24 Billion | 11.58% | 0.08x | $1.12 Billion |
About SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, ligh… Read more